Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing

Simona Pozza, Armanda De Marchi, Chiara Albertin, Domenico Albano, Ginevra Biino, Domenico Aloj, Luca Maria Sconfienza

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To assess the technical feasibility of contrast-enhanced ultrasound (CEUS) in the monitoring of non-infected long bone nonunion healing. Methods: Twenty-five patients (16 males; mean age: 40.4 ± 11.7) with long bone nonunion were treated using surgery and mesenchymal stem cells and platelet-rich plasma. They performed CEUS up to 15 days before, 7 days, 4 and 8 weeks after treatment. To categorize the angiogenesis around the fracture site, the microvascular blood flow from CEUS was classified into four categories, depending on the portion of the investigated area that was involved in the neovascularization process: grade 0 = 0%; grade 1 = 0–30%; grade 2 = 30–70%; grade 3 = 70–100%. Nonparametric Friedman and Wilcoxon statistics were used. Results: Before treatment, neovascularization was graded as 0 in 15/25 patients, as 1 in 10/25. Vascularity significantly increased over time (P < 0.001), namely: 1 (25th–75th percentile = 1–2) at 7 days; 2 (1–2) at 4 weeks; 3 (0–2) at 8 weeks. All patients but one showed early progressive increase in neovascularization well identified with CEUS at the fracture site. Conclusion: CEUS is a feasible method to monitor healing in patients with long bone nonunion.

Original languageEnglish
Pages (from-to)703-709
Number of pages7
JournalRadiologia Medica
Volume123
Issue number9
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Bone and Bones
Platelet-Rich Plasma
Mesenchymal Stromal Cells
Therapeutics

Keywords

  • Contrast-enhanced ultrasound
  • Long bone nonunion
  • Mesenchymal stem cells
  • Platelet-rich plasma
  • Ultrasound

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing. / Pozza, Simona; De Marchi, Armanda; Albertin, Chiara; Albano, Domenico; Biino, Ginevra; Aloj, Domenico; Sconfienza, Luca Maria.

In: Radiologia Medica, Vol. 123, No. 9, 01.09.2018, p. 703-709.

Research output: Contribution to journalArticle

Pozza, Simona ; De Marchi, Armanda ; Albertin, Chiara ; Albano, Domenico ; Biino, Ginevra ; Aloj, Domenico ; Sconfienza, Luca Maria. / Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing. In: Radiologia Medica. 2018 ; Vol. 123, No. 9. pp. 703-709.
@article{5cc8ef7f858b462d8ed7ca8d53f80325,
title = "Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing",
abstract = "Purpose: To assess the technical feasibility of contrast-enhanced ultrasound (CEUS) in the monitoring of non-infected long bone nonunion healing. Methods: Twenty-five patients (16 males; mean age: 40.4 ± 11.7) with long bone nonunion were treated using surgery and mesenchymal stem cells and platelet-rich plasma. They performed CEUS up to 15 days before, 7 days, 4 and 8 weeks after treatment. To categorize the angiogenesis around the fracture site, the microvascular blood flow from CEUS was classified into four categories, depending on the portion of the investigated area that was involved in the neovascularization process: grade 0 = 0{\%}; grade 1 = 0–30{\%}; grade 2 = 30–70{\%}; grade 3 = 70–100{\%}. Nonparametric Friedman and Wilcoxon statistics were used. Results: Before treatment, neovascularization was graded as 0 in 15/25 patients, as 1 in 10/25. Vascularity significantly increased over time (P < 0.001), namely: 1 (25th–75th percentile = 1–2) at 7 days; 2 (1–2) at 4 weeks; 3 (0–2) at 8 weeks. All patients but one showed early progressive increase in neovascularization well identified with CEUS at the fracture site. Conclusion: CEUS is a feasible method to monitor healing in patients with long bone nonunion.",
keywords = "Contrast-enhanced ultrasound, Long bone nonunion, Mesenchymal stem cells, Platelet-rich plasma, Ultrasound",
author = "Simona Pozza and {De Marchi}, Armanda and Chiara Albertin and Domenico Albano and Ginevra Biino and Domenico Aloj and Sconfienza, {Luca Maria}",
year = "2018",
month = "9",
day = "1",
doi = "10.1007/s11547-018-0902-7",
language = "English",
volume = "123",
pages = "703--709",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "9",

}

TY - JOUR

T1 - Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing

AU - Pozza, Simona

AU - De Marchi, Armanda

AU - Albertin, Chiara

AU - Albano, Domenico

AU - Biino, Ginevra

AU - Aloj, Domenico

AU - Sconfienza, Luca Maria

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Purpose: To assess the technical feasibility of contrast-enhanced ultrasound (CEUS) in the monitoring of non-infected long bone nonunion healing. Methods: Twenty-five patients (16 males; mean age: 40.4 ± 11.7) with long bone nonunion were treated using surgery and mesenchymal stem cells and platelet-rich plasma. They performed CEUS up to 15 days before, 7 days, 4 and 8 weeks after treatment. To categorize the angiogenesis around the fracture site, the microvascular blood flow from CEUS was classified into four categories, depending on the portion of the investigated area that was involved in the neovascularization process: grade 0 = 0%; grade 1 = 0–30%; grade 2 = 30–70%; grade 3 = 70–100%. Nonparametric Friedman and Wilcoxon statistics were used. Results: Before treatment, neovascularization was graded as 0 in 15/25 patients, as 1 in 10/25. Vascularity significantly increased over time (P < 0.001), namely: 1 (25th–75th percentile = 1–2) at 7 days; 2 (1–2) at 4 weeks; 3 (0–2) at 8 weeks. All patients but one showed early progressive increase in neovascularization well identified with CEUS at the fracture site. Conclusion: CEUS is a feasible method to monitor healing in patients with long bone nonunion.

AB - Purpose: To assess the technical feasibility of contrast-enhanced ultrasound (CEUS) in the monitoring of non-infected long bone nonunion healing. Methods: Twenty-five patients (16 males; mean age: 40.4 ± 11.7) with long bone nonunion were treated using surgery and mesenchymal stem cells and platelet-rich plasma. They performed CEUS up to 15 days before, 7 days, 4 and 8 weeks after treatment. To categorize the angiogenesis around the fracture site, the microvascular blood flow from CEUS was classified into four categories, depending on the portion of the investigated area that was involved in the neovascularization process: grade 0 = 0%; grade 1 = 0–30%; grade 2 = 30–70%; grade 3 = 70–100%. Nonparametric Friedman and Wilcoxon statistics were used. Results: Before treatment, neovascularization was graded as 0 in 15/25 patients, as 1 in 10/25. Vascularity significantly increased over time (P < 0.001), namely: 1 (25th–75th percentile = 1–2) at 7 days; 2 (1–2) at 4 weeks; 3 (0–2) at 8 weeks. All patients but one showed early progressive increase in neovascularization well identified with CEUS at the fracture site. Conclusion: CEUS is a feasible method to monitor healing in patients with long bone nonunion.

KW - Contrast-enhanced ultrasound

KW - Long bone nonunion

KW - Mesenchymal stem cells

KW - Platelet-rich plasma

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85046401078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046401078&partnerID=8YFLogxK

U2 - 10.1007/s11547-018-0902-7

DO - 10.1007/s11547-018-0902-7

M3 - Article

VL - 123

SP - 703

EP - 709

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 9

ER -